Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga June 10, 2015 at 08:17 AM EDT Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 11.32 percent to $89.15 in pre-market after falling 0.24 percent on Tuesday. ... Read More >> Related Stocks: Bluebird Bio Esperion Theraptc Francesca's Holdings Gulfport Energy Corp Regeneron Pharmaceuticals